Skip to content

Twitter page opens in new window Linkedin page opens in new window Instagram page opens in new window

info@pharmaust.com+61 8 9202 6814

PharmAust (PAA)

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

Daily Archives: December 13, 2017

Phase II Dog Lymphoma Trial Confirms Monepantel Clinical Benefit

News & Announcements 2017By Richard Hopkins December 13, 2017

171211_Lymphoma Trial Result_(clean)

Recent Articles

Epichem Corporate Presentation July 2020
July 2, 2020
PharmAust Shareholder Update Presentation June 2020
July 2, 2020
June 30, Top 20 Shareholders
July 1, 2020
JP Equity Partners – Broker Analyst Report – July 2020
June 30, 2020

MENU

Home
About Us
Pipeline & Trials
Investor Centre
Media
Contact Us

SUBSCRIBE TO OUR NEWSLETTER

Leave this field empty if you're human:

TWITTER

PharmAustFollow

Retweet on Twitter PharmAust Retweeted

Elanco@Elanco·

Cancer is the most treatable of all chronic diseases in dogs and cats. The single most important thing to enhance the cure rate is early detection and diagnosis.

Reply on Twitter 1280954861442543622 Retweet on Twitter 12809548614425436223 Like on Twitter 128095486144254362215 Twitter 1280954861442543622

Copyright © 2020 Pharmaust. All rights reserved.

Website Design & Digital Marketing Perth by Total Click Solutions